Baudax Bio Other Current Liabilities

Baudax Bio (BXRX) currently reports a other current liabilities of $2.1M as of September 2023. That compares with $12M in the prior-year period — down 81.9% year over year. Use the charts on this page to explore Baudax Bio's other current liabilities history and peer comparisons.

Baudax Bio's other current liabilities decreased from $12M to $2.1M — a 81.9% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Baudax Bio reported $2.1M in other current liabilities as of September 2023. That compares with $12M in the prior-year period — down 81.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $2.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Baudax Bio, and consider following BXRX for alerts when major investors trade the stock.

Baudax Bio is classified in the Healthcare sector. On other current liabilities, it currently shows $2.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BXRX with unrelated industries.